Oral Azithromycin
Oral azithromycin in extended dosage schedule for chronic, subclinical <em>Chlamydia pneumoniae</em> infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial
... of oral azithromycin once daily for 5 days, which was then repeated after a gap of 10 days (total of 24 courses in the 1-year trial ...have azithromycin added to their standard CAD ...
5
To study the effectiveness of oral azithromycin as compared to parenteral ceftriaxone in the treatment of uncomplicated enteric fever.
... received oral Azithromycin (20mg/kg/day) and the other group received parenteral Ceftriaxone (75mg/kg/day), both of which were given for a duration of 7 ...the Azithromycin group had defervesced ...
123
Role of oral azithromycin in the treatment of ocular toxoplasmosis.
... 4000/cc, platelet count below 100,000/cc or if either decreases 25-50% below the baseline. Rothova and associates found a relationship between treatment with Pyrimethamine and Sulfadiazine and reduction of lesion size. ...
119
EFFECT OF ORAL AZITHROMYCIN AND METRONIDAZOLE AS AN ADJUNCT TO SCALING AND ROOT PLANING ON GLYCEMIC CONTROL IN TYPE II DIABETIC PATIENTS WITH CHRONIC PERIODONTITIS
... in oral cavity and poor dental prognosis, patients who are allergic to azithromycin and metronidazole and patients with major medical complications were excluded from the ...
5
Clinical pharmacology of azithromycin in infants and children
... either azithromycin (body-weight ≤ 40 kg: 250 mg once-daily, > 40 kg: 500 mg) or placebo for 6 months ...between azithromycin and placebo was ...fewer oral antibiotic courses when ...
15
Formulation and Product Development of Azithromycin Tablets .
... of Azithromycin in healthy volunteers given five oral ...of oral Azithromycin were studied in 25 healthy volunteers, each of whom received an initial dose of 500 mg and then 250 mg once daily ...
133
Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis
... with azithromycin treatment failure (59, ...single-dose oral azithromycin in treating chlamydial infections and the increasing concerns about the serious complications caused by the poor-to-moderate ...
18
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model
... resistance. Azithromycin is presently one of the few oral antibiotic options that can be reliably used for typhoid treatment, although concerns persist regarding variations in response to treatment and ...
34
Bronchiectasis exacerbation study on azithromycin and amoxycillin clavulanate for respiratory exacerbations in children (BEST 2): study protocol for a randomized controlled trial
... empirical oral-antibiotic treatment for non-severe bronchiectasis exacerbations in children ...children. Oral azithromycin is attractive as an alternative first-line therapy because of its long ...
10
Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study
... to-oral azithromycin therapy demonstrated excellent clin- ical and bacteriological effects on moderate-to-severe pneumococcal pneumonia despite a high MIC and resist- ance gene development ...
6
Men at risk of gonococcal urethritis: a case control study in a Darwin sexual health clinic
... of oral azithromycin 1 g for syndromic treatment for male urethritis, with an additional dose of intramus- cular ceftriaxone 500 mg for treatment of presumed gon- orrhoea in high risk groups ...with ...
7
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN HEMIHYDRATE AND AMBROXOL HYDROCHLORIDE IN THE PHARMACEUTICAL DOSAGE FORM
... The method described enables the quantification of LEV and AMB in combined tablet dosage form. The validation data demonstrates good precision and accuracy which proves to be reliable of the proposed method. Hence, this ...
8
DESIGN DEVELOPMENT AND EVALUATION OF NANOSUSPENSION OF AZITHROMYCIN
... Formulation of Nanosuspensions of Azithromycin Azithromycin nanosuspensions were formed by bottom-up technique. In this method the nanosuspensions were prepared by solvent-antisolvent precipitation ...
11
Azithromycin resistance in Shigella spp in Southeast Asia
... Azithromycin resistance in Shigella spp in Southeast Asia 1 Azithromycin resistance in Shigella spp in Southeast Asia 1 2 Thomas C Darton 1,2 , Ha Thanh Tuyen 1 , Hao Chung The 1 , Paul N Newton 3,4 ,[.] ...
29
Pregnancy outcome following gestational exposure to azithromycin
... to azithromycin were compared to two comparison groups consisting of women not exposed to azithromycin who were matched by maternal age (± 2 years), gestational age at the time of call (± 2 weeks), alco- ...
5
Azithromycin resistance in Shigella spp. in Southeast Asia
... Tel: +84 89241761 Fax: +84 89238904 [email protected] Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical Faculty of Infectious and Tropical Dise[r] ...
29
High Frequency of Macrolide-Resistant Streptococcus pneumoniae Colonization in Respiratory Tract of Healthy Children in Ardabil, Iran
... Macrolides are increasingly used in the treatment of diseases caused by S. pneumoniae (8). In this study, we evaluated the prevalence of macrolide resistance in S. pneumoniae isolates collected from healthy children in ...
8
Pattern of Antimicrobial Sensitivity of Organisms Causing Urinary Tract Infection in Nephrotic Syndrome in Children
... both oral and parenteral antibiotics were quite high like other study ...of oral drugs, only ciprofloxacin were more or less effective in 100% ...active oral drug against majority of uropathogens ...
6
Azithromycin Does Not Cure Pityriasis Rosea
... OBJECTIVES. Pityriasis rosea (PR) is a common skin disorder in children. Its cause is unknown. A recent publication reported a 73% cure rate in patients with PR after treatment with erythromycin. To duplicate this result ...
6
Azithromycin in Early Infancy and Pyloric Stenosis
... of azithromycin in neonates (Fig ...recommend azithromycin as the drug of choice for treatment or prophylaxis of pertussis in infants younger than 1 month of age because the risk ...
8